Theratechnologies Eulerpool Novinky

Theratechnologies Novinky o akciách

Theratechnologies sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy Theratechnologies zhromažďujeme práve tu.

• 9. januára ·

  Yahoo
  Theratechnologies Provides Update on EGRIFTA SV® Supply
• 10. decembra ·

  Yahoo
  Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA
• 9. decembra ·

  Yahoo
  Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer
• 4. decembra ·

  Yahoo
  Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada
• 26. novembra ·

  Yahoo
  Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review
• 25. novembra ·

  Yahoo
  Theratechnologies Inc. (TSE:TH) Has Found A Path To Profitability
• 17. októbra ·

  Yahoo
  Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab
• 17. októbra ·

  Yahoo
  Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance
• 11. októbra ·

  Yahoo
  Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
• 10. októbra ·

  Yahoo
  Theratechnologies Up 12% in U.S. Premarket Trading After Reporting Q3 Swing to Profit